...
首页> 外文期刊>Journal of materials science >In vivo assessment of the osteointegrative potential of phosphatidylserine-based coatings
【24h】

In vivo assessment of the osteointegrative potential of phosphatidylserine-based coatings

机译:磷脂酰丝氨酸基涂层骨整合潜力的体内评估

获取原文
获取原文并翻译 | 示例

摘要

The successful implantation of titanium-based implants for orthopaedic and dental applications is often hindered because of their mobility, which arises because of a lack of direct binding of the metal surface to the mineral phase of the surrounding bone. Ceramic coatings, although ensuring the integration of the implant within the tissue, are unstable and carry risks of delamination and of failure. Recently, a novel biomimetic approach has been developed where porous titanium implants are coated with calcium-binding phospholipids able to catalyse the nucleation of discrete apatite crystals after only 30 min incubation in simulated body fluids.rnThe present work assesses the osteointegrative potential of this new class of coatings in an in vivo rabbit model and compares its performance with those of bare porous titanium and hydroxyapatite-coated titanium.rnThe data obtained show that phosphatidylserine-based coatings, whilst resorbing, drive the growing bone into apposition with the metal surface. This is in contrast to the case of bare titanium.
机译:钛基植入物用于骨科和牙科应用的成功植入常常因其活动性而受到阻碍,这是由于缺乏金属表面与周围骨骼的矿物相的直接结合而引起的。陶瓷涂层虽然确保了植入物在组织内的整合,但仍不稳定,并具有分层和失效的风险。最近,已经开发出一种新型的仿生方法,其中多孔钛植入物涂有钙结合磷脂,能够在模拟体液中孵育30分钟后催化离散的磷灰石晶体成核.rn本工作评估了这一新类别的骨整合潜力。体内兔子模型中的涂层的性能比较,并将其与裸露的多孔钛和羟基磷灰石涂层的钛的性能进行比较。获得的数据表明,磷脂酰丝氨酸基涂层在吸收的同时,驱使生长中的骨骼与金属表面并置。这与裸钛的情况相反。

著录项

  • 来源
    《Journal of materials science 》 |2006年第9期| 789-794| 共6页
  • 作者单位

    Universita' Cattolica, Clinica Ortopedica, Rome, Italy;

    Universita' del Piemonte Orientale, Dipartimento Scienze Mediche, Novara, Italy;

    Universita' Cattolica, Clinica Ortopedica, Rome, Italy;

    University of Brighton, School of Pharmacy & Biomolecular Sciences, Brighton, UK;

    Welsh School of Pharmacy, Cardiff University, Cardiff, UK;

    Destiny Pharma Ltd, Brighton, UK;

    Destiny Pharma Ltd, Brighton, UK;

    Universita' di Parma, Dipartimento di Salute Animale, Parma, Italy;

    Universita' di Parma, Dipartimento di Salute Animale, Parma, Italy;

    Universita' di Sassari, Clinica Ortopedica, Italy;

    Universita' del Piemonte Orientale, Dipartimento Scienze Mediche, Novara, Italy;

    University of Brighton, School of Pharmacy & Biomolecular Sciences, Brighton, UK;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号